News | December 15, 2021
NATCO Pharma to acquire Dash Pharmaceuticals
The cash consideration for the acquisition is US$ 18 million.
The cash consideration for the acquisition is US$ 18 million.
The current round is led by IIFL Asset Management (IIFL AMC) along with investment from existing investors InvestCorp and Bessemer Venture Partners (BVP)
Intox is a GLP certified pre-clinical contract research organization with its test facilities in Pune
The campaign “Care is Just An Aster Away” was launched along with the unveiling of the new corporate logo on Burj Khalifa on 11th December
Saroglitazar Mg is an investigational compound in the USA, and is yet to be approved by the U.S. Food & Drug Administration (USFDA) or European Medicines Agency (EMA)
He has more than 285 publications with 7,600 citations, 80 students have already been awarded Ph. D. degree under his able guidance and 20 postdoctoral associates have worked in his group
The Institute of Pulmonology Medical Research & Development organised a symposium on early management of Covid-19
Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever
Rad-G is a rugged, portable, handheld Masimo SET Measure-through Motion and Low Perfusion pulse oximeter and noninvasive respiration rate monitor
Maharashtra won the award for the highest number of deceased donors transplantations
Subscribe To Our Newsletter & Stay Updated
